Author

Zachery Roger Reichert

University of MichiganORCID 0000-0003-0356-8796Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:clustering· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Approach:mechanistic / dynamical model· 1

Frequent Co-Authors

Arul M. ChinnaiyaniD· 2 shared Xuhong CaoiD· 2 shared Abhijit ParoliaiD· 1 shared Anbarasu KumaraswamyiD· 1 shared Caleb ChengiD· 1 shared Chungen LiiD· 1 shared Costas Andreas LyssiotisiD· 1 shared Dan R. RobinsoniD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Arul M. ChinnaiyanORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyCancer CellPeer-reviewedAug 3, 2026

A Stress-Adaptive Lipid Kinase Axis Defines Metabolic Vulnerabilities in Neuroendocrine Prostate Cancer

Yang Zheng, Caleb Cheng, Yizhi Cao…·Yuanyuan Qiao

This study identifies a stress-lipid kinase axis in NEPC driven by PIKfyve, revealing a synthetic vulnerability between PIKfyve and FASN that can be exploited for therapeutic targeting.

DOI 10.1016/j.ccell.2026.07.003

humanmetabolomics

𝕏 PostBluesky

Cancer BiologybioRxivPreprintJun 20, 2026

Genomic Determinants of Lethality and Therapeutic Vulnerability in Castration-Resistant Prostate Cancer

Ryan James Rebernick, Liat Hammer, Mahnoor Naseer Gondal…·Marcin Cieslik

This study identifies genomic drivers of progression and therapeutic outcomes in mCRPC and develops a multi-omic classifier to predict patient survival across multiple therapies.

DOI 10.64898/2026.06.18.733209

humanwhole-genome sequencing

𝕏 PostBluesky